BCLI brainstorm-cell.com Expected net earnings per share growth this year
Brainstorm Cell (BCLI) is developing the unique NurOwn therapy, utilizing a patient's own stem cells to combat ALS. The firm's financial stability relies on external investments and grants, as it currently generates no operating income. Development is proceeding through partnerships with funds without mergers. The annual net income per share chart visualizes these processes, where the 30.50 level indicates the state of the parameter.
Analytical breakdowns and data insights for company Brainstorm Cell (BCLI)
- stock quotes and analyst forecast:
- market capitalization data:
- shareholders' equity book value data:
- debt and solvency information:
All Debt to Shareholders' Equity Ratio Brainstorm Cell|BCLI - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio brainstorm-cell.com|BCLI - Company Total Debt|Debt to Net Assets Ratio BrainStorm Cell Therapeutics Inc.|BCLI - Company Long-Term Debts|Company Current Liabilities BrainStorm Cell Therapeutics|Immediate Liquidity brainstorm-cell.com
- earnings and valuation multiples indicators:
BCLI - Company Net Income|Expected Profit Brainstorm Cell|BCLI - Price to Earnings Ratio|Future Price to Earnings BrainStorm Cell Therapeutics Inc.|BCLI - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BrainStorm Cell Therapeutics Inc.|BCLI - Operating profit EBITDA|Net earnings per share for the last 12 months BrainStorm Cell Therapeutics|BCLI - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months brainstorm-cell.com|BCLI - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Brainstorm Cell
Summary company analysis:Brainstorm Cell Therapeutics Inc. (BCLI)
This metric measures the year-over-year dynamics of earnings per share, smoothing out time gaps between quarterly reports to assess the actual efficiency of the business. By analyzing the annual EPS growth trajectory, an investor separates market volatility from fundamental profitability trends. For Brainstorm Cell (BCLI), this metric is critical, as geopolitical isolation and logistical collapse are hindering international research, directly impacting the financial result.
Direct competitors
Earnings per share growth this year BIIB|Earnings per share growth in current year Neurocrine Biosciences Inc|Regencell Corp (RGC) - Expected net earnings per share growth this year|Net earnings per share growth this year AXSM (Axsome Therapeutics)|Net earnings per one share growth for the current year ACAD|Earnings per share growth in current year Xenon XENE|Viking Therapeutics Inc (VKTX) - Earnings per share growth rate in current year|SUPN - Earnings per share growth in current year|Earnings per share increase in current year CPRX (Catalyst Corp)|Denali Therapeutics (DNLI) - Earnings per share growth in current year|Net earnings per share growth this year harmonybiosciences.com|Net earnings per share growth this year BHVN|AMLX: Earnings per share increase in current year|Earnings growth in current year TRVI|Net earnings per share growth this year Praxis Corp PRAX|Earnings growth in current year AVXL (Anavex Life Sciences)|ceribell.com (CBLL) - Earnings per share growth rate in current year|PRTA - Earnings per share growth in current year|ALEC: Earnings per share growth in current year|Annexon Inc. (ANNX) - Earnings per share growth in current year|OMER (Omeros) - Earnings per share growth in current year|NGNE (Neurogene Inc.) - Earnings growth in current year|Earnings per share growth in current year ACIU|Earnings growth in current year VYGR|Net earnings per share growth this year Neumora NMRA|Earnings per share growth in current year Scilex Holding Co. SCLX|Tevogen Bio Inc. - Earnings per share growth in current year|Alpha Cognition Corp - Earnings growth in current year|Expected net earnings per share growth this year Cognition Therapeutics Inc. CGTX|Inhibikase Therapeutics, Inc. (IKT) - Earnings per share growth in current year|Earnings per share growth this year SAVA|ASRT (Assertio Holdings) - Earnings growth in current year|Earnings per share growth rate in current year Coya COYA|Net earnings per share growth this year VTGN (Vistagen Therapeutics)|Earnings growth in current year ovidrx.com (OVID)|Earnings per share growth in current year Acumen Pharmaceuticals, Inc. ABOS|Earnings per share increase in current year CRVO|ATHE - Earnings per share growth in current year|Earnings per share growth rate in current year Clene Inc.|PEPG: Earnings growth in current year|JUNS (Jupiter Neurosciences, Inc.) - Earnings per share growth in current year|Earnings per share growth in current year Relmada Therapeutics, Inc.|ANVS: Earnings per share increase in current year|Earnings growth in current year GRCE|Earnings growth in current year Firefly Neuro (AIFF)|Earnings growth in current year KLTO (Klotho Neurosciences)|Expected net earnings per share growth this year NeuroSense Therapeutics Ltd (NRSN)|RVPH - Earnings per share growth in current year|MTVA (MetaVia Inc) - Earnings per share growth this year|NeurAxis, Inc (NRXS) - Earnings per share growth in current year|HSDT - Expected net earnings per share growth this year|Net earnings per share growth this year PASG|NEUP (Neuphoria) - Net earnings per one share growth for the current year|Earnings per share growth in current year Minerva Neurosciences, Inc. (NERV)|ATHA - Earnings per share growth rate in current year|Earnings per share growth in current year Addex Therapeutics, Ltd. ADXN|Earnings per share increase in current year ALZN|CYCN - Earnings per share growth in current year|Protagenic Therapeutics (PTIX) - Net earnings per share growth this year|KTTA (pasitheaclinics.com) - Net earnings per share growth this year|Cortigent - Earnings per share increase in current year|ATXI (Avenue Therapeutics, Inc) - Earnings growth in current year|Net earnings per share growth this year Cara Therapeutics Inc (CARA)|Earnings growth in current year CHRO|ELYM - Earnings per share growth rate in current year|Earnings per share growth in current year Intra-Cellular Therapies, Inc. ITCI|Longboard Pharmaceuticals Inc - Earnings per share growth in current year|MRNS - Earnings per share growth in current year|NKGN: Earnings per share growth in current year|NRBO: Earnings growth in current year|SAGE (sagerx.com) - Earnings per share growth in current year|SNPX (Synaptogenix) - Earnings growth in current year|Net earnings per share growth this year Trevena Inc. (TRVN)|Earnings per share growth in current year Vigil Neuroscience (VIGL)|Earnings per share growth in current year WENA (anewmeds.com)|Earnings growth in current year CERE (Cerevel Therapeutics)
